Recombinant multi-species IL-17F/IL17F protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-17F/IL17F protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
The protein encoded by this gene is a cytokine that shares sequence similarity with IL17. This cytokine is expressed by activated T cells, and has been shown to stimulate the production of several other cytokines, including IL6, IL8, and CSF2/GM_CSF. This cytokine is also found to inhibit the angiogenesis of endothelial cells and induce endothelial cells to produce IL2, TGFB1/TGFB, and monocyte chemoattractant protein-1. [provided by RefSeq, Jul 2008]
The Alternative Names of target: CANDF6,Cytokine ML-1,IL-17F,IL17A,IL17F,Il17f,Interleukin-17F,ML-1,ML1

Target products collectionGo to IL-17F/IL17F products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-T06542-Ag-1/ GM-Tg-hg-T06542-Ag-2 Human IL-17F/IL17F protein Human
GM-Tg-rg-T06542-Ag-1/ GM-Tg-rg-T06542-Ag-2 Rat IL-17F/IL17F protein Rat
GM-Tg-mg-T06542-Ag-1/ GM-Tg-mg-T06542-Ag-2 Mouse IL-17F/IL17F protein Mouse
GM-Tg-cynog-T06542-Ag-1/ GM-Tg-cynog-T06542-Ag-2 Cynomolgus/Rhesus macaque IL-17F/IL17F protein Cynomolgus/ Rhesus macaque
GM-Tg-felg-T06542-Ag-1/ GM-Tg-felg-T06542-Ag-2 Feline IL-17F/IL17F protein Feline
GM-Tg-cang-T06542-Ag-1/ GM-Tg-cang-T06542-Ag-2 Canine IL-17F/IL17F protein Canine
GM-Tg-bovg-T06542-Ag-1/ GM-Tg-bovg-T06542-Ag-2 Bovine IL-17F/IL17F protein Bovine
GM-Tg-equg-T06542-Ag-1/ GM-Tg-equg-T06542-Ag-2 Equine IL-17F/IL17F protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-T06542-Ag-1/ GM-Tg-hg-T06542-Ag-2; GM-Tg-rg-T06542-Ag-1/ GM-Tg-rg-T06542-Ag-2;
GM-Tg-mg-T06542-Ag-1/ GM-Tg-mg-T06542-Ag-2; GM-Tg-cynog-T06542-Ag-1/ GM-Tg-cynog-T06542-Ag-2;
GM-Tg-felg-T06542-Ag-1/ GM-Tg-felg-T06542-Ag-2; GM-Tg-cang-T06542-Ag-1/ GM-Tg-cang-T06542-Ag-2;
GM-Tg-bovg-T06542-Ag-1/ GM-Tg-bovg-T06542-Ag-2; GM-Tg-equg-T06542-Ag-1/ GM-Tg-equg-T06542-Ag-2
Products Name IL-17F/IL17F protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name IL-17F/IL17F
Protein Sub-location Secreted Protein/Potential Cytokines
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine IL-17F/IL17F protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.